EP0587775A4 - Induction of ctl responses to foreign antigens expressed in mycobacteria. - Google Patents

Induction of ctl responses to foreign antigens expressed in mycobacteria.

Info

Publication number: EP0587775A4
Authority: EP; European Patent Office
Prior art keywords: mycobacteria; induction; ctl responses; antigens expressed; foreign antigens
Prior art date: 1991-06-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP9292913615A

Other languages

German (de)

French (fr)

Other versions

EP0587775A1 (en

Inventor

Charles K Stover

Cruz Vidal Dela

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

MedImmune LLC

Original Assignee

MedImmune LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-06-06

Filing date

1992-06-01

Publication date

1994-11-02

1992-06-01 Application filed by MedImmune LLC filed Critical MedImmune LLC

1994-03-23 Publication of EP0587775A1 publication Critical patent/EP0587775A1/en

1994-11-02 Publication of EP0587775A4 publication Critical patent/EP0587775A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Microbiology (AREA)
Public Health (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Virology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

EP9292913615A 1991-06-06 1992-06-01 Induction of ctl responses to foreign antigens expressed in mycobacteria. Withdrawn EP0587775A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US71164391A	1991-06-06	1991-06-06
US711643		1991-06-06

Publications (2)

Publication Number	Publication Date
EP0587775A1 EP0587775A1 (en)	1994-03-23
EP0587775A4 true EP0587775A4 (en)	1994-11-02

Family

ID=24858927

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP9292913615A Withdrawn EP0587775A4 (en)	1991-06-06	1992-06-01	Induction of ctl responses to foreign antigens expressed in mycobacteria.

Country Status (4)

Country	Link
EP (1)	EP0587775A4 (en)
AU (1)	AU2185592A (en)
CA (1)	CA2110682A1 (en)
WO (1)	WO1992021376A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2153391C (en)	1993-01-11	2000-08-15	Kenneth Rock	Inducing cytotoxic t lymphocyte responses
US6752993B1 (en)	1993-11-23	2004-06-22	The Regents Of The University Of California	Abundant extracellular product vaccines and methods for their production and use
JPH09505588A (en)	1993-11-23	1997-06-03	ザリージェンツオブザユニバーシティオブカリフォルニア	Many extracellular products and their methods of manufacture and use
US7300660B2 (en)	1993-11-23	2007-11-27	The Regents Of The University Of California	Abundant extracellular products and methods for their production and use
GB9426153D0 (en) *	1994-12-23	1995-02-22	Medical Res Council	Improvements in or relating to vaccines
US6013660A (en) *	1996-10-02	2000-01-11	The Regents Of The University Of California	Externally targeted prophylactic and chemotherapeutic method and agents
WO2000011181A1 (en)	1998-08-20	2000-03-02	Connaught Laboratories Limited	NUCLEIC ACID MOLECULES ENCODING INCLUSION MEMBRANE PROTEIN C OF $i(CHLAMYDIA)
US6686339B1 (en)	1998-08-20	2004-02-03	Aventis Pasteur Limited	Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
US6693087B1 (en)	1998-08-20	2004-02-17	Aventis Pasteur Limited	Nucleic acid molecules encoding POMP91A protein of Chlamydia
WO2001030847A1 (en)	1999-10-22	2001-05-03	Aventis Pasteur Limited	Modified gp100 and uses thereof
EP1792995A3 (en)	2000-05-08	2007-06-13	Sanofi Pasteur Limited	Chlamydia secretory locus orf and uses thereof
PT1282702E (en)	2000-05-10	2007-02-28	Ludwig Inst Cancer Res	Immunogenic polypeptides encoded by mage minigenes and uses thereof
WO2002016440A2 (en)	2000-08-25	2002-02-28	Aventis Pasteur Limited	Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections
EP1343894A4 (en)	2000-11-02	2005-05-04	Univ Singapore	AOPB GENE, PROTEIN, HOMOLOGY, FRAGMENTS AND VARIANTS THEREOF AND THEIR USE IN CELL SURFACE PRESENTATION
US8921534B2 (en)	2001-12-12	2014-12-30	Sanofi Pasteur Limited	Enhancement of the immune response using CD36-binding domain
AU2003223527B2 (en)	2002-04-09	2009-01-15	Sanofi Pasteur Limited	Modified CEA nucleic acid and expression vectors
EP2376526A4 (en)	2008-12-24	2013-02-27	Kingdom Of The Netherlands Represented By The Min Ister Of Health Welfare & Sport On Behalf Of The M	Modified streptococcus pneumoniae pneumolysin (ply) polypeptides
EP2668201A2 (en)	2011-01-28	2013-12-04	Sanofi Pasteur SA	Immunological compositions comprising hiv gp41 polypeptide derivatives
US9090667B2 (en) *	2011-04-18	2015-07-28	Myongji University Industry And Academia Cooperation Foundation	Cyclic peptide from Nonomuraea sp., process for the production thereof, and pharmaceutical composition for the prevention or treatment of mycobacteria related disease comprising the same
US9717781B2 (en)	2011-08-08	2017-08-01	Alexander Shneider	Methods and compositions relating to P62 for the treatment and prophylaxis of cancer
CA2884918C (en)	2012-09-17	2019-01-08	Novartis Tiergesundheit Ag	Salmonid alphavirus and uses thereof
US9809863B2 (en)	2012-11-02	2017-11-07	Elanco Tiergesundheit Ag	Flavivirus associated with Theiler's disease
WO2014140938A2 (en)	2013-03-14	2014-09-18	Centre Hospitalier Universitaire Vaudois	Immunological methods
KR102422580B1 (en)	2013-12-29	2022-07-20	큐어랩 온콜로지, 인크.	Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseases
PL3177644T3 (en)	2014-08-05	2021-06-14	MabQuest SA	Immunological reagents binding to pd-1
WO2017093985A1 (en)	2015-12-05	2017-06-08	Centre Hospitalier Universitaire Vaudois	Hiv binding agents
AU2017208819B2 (en)	2016-01-22	2023-10-19	MabQuest SA	PD1 specific antibodies
WO2020012435A1 (en)	2018-07-13	2020-01-16	Lausanne University Hospital	Hiv binding agents
WO2021009697A2 (en)	2019-07-15	2021-01-21	Lausanne University Hospital	Hiv binding agents
TW202206098A (en)	2020-08-11	2022-02-16	美商碩騰服務公司	Anti-coronavirus vaccines
CN114315985A (en)	2020-09-29	2022-04-12	硕腾服务有限责任公司	Attenuated porcine epidemic diarrhea virus
US20240390476A1 (en)	2021-08-31	2024-11-28	Zoetis Services Llc	Attenuated alphavirus

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1988006626A1 (en) *	1987-03-02	1988-09-07	Whitehead Institute For Biomedical Research	Recombinant mycobacterial vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5504005A (en) *	1987-03-02	1996-04-02	Albert Einstein College Of Medicine Of Yeshiva University	Recombinant mycobacterial vaccine

1992
- 1992-06-01 EP EP9292913615A patent/EP0587775A4/en not_active Withdrawn
- 1992-06-01 WO PCT/US1992/004538 patent/WO1992021376A1/en not_active Application Discontinuation
- 1992-06-01 CA CA002110682A patent/CA2110682A1/en not_active Abandoned
- 1992-06-01 AU AU21855/92A patent/AU2185592A/en not_active Abandoned

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1988006626A1 (en) *	1987-03-02	1988-09-07	Whitehead Institute For Biomedical Research	Recombinant mycobacterial vaccine

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ANNA ALDOVINI ET AL.: "Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines", NATURE, vol. 351, no. 6326, 6 June 1991 (1991-06-06), LONDON GB, pages 479 - 482 *
Annual meeting on modern approaches to new vaccines, 8th, Cold Spring Harbor, N. Y., September, 1990 *
C.K. STOVER ET AL.: "New use of BCG for recombinant vaccines", NATURE, vol. 351, no. 6326, 6 June 1991 (1991-06-06), LONDON GB, pages 456 - 460 *
See also references of WO9221376A1 *
VIDAL F. DE LA CRUZ ET AL.: "Humoral and cellular immune responses to recombinant Mycobacteria (BCG)", VACCINES 91: MODERN APPROACHES TO NEW VACCINES INCLUDING PREVENTION OF AIDS, 1991, pages 399 - 402 *

Also Published As

Publication number	Publication date
WO1992021376A1 (en)	1992-12-10
EP0587775A1 (en)	1994-03-23
AU2185592A (en)	1993-01-08
CA2110682A1 (en)	1992-12-10

Publication	Publication Date	Title
EP0587775A4 (en)	1994-11-02	Induction of ctl responses to foreign antigens expressed in mycobacteria.
GB2260898B (en)	1995-11-15	Power slider
AP9200376A0 (en)	1992-04-30	Novel antibodies and methods for their use
DK99288D0 (en)	1988-02-25	GRINDING TOPIC
OA09809A (en)	1994-04-15	Mococlonal antibodies to ELAM-1 and their uses.
EP0722738A3 (en)	1996-10-23	Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations
AU7613291A (en)	1992-11-26	Improvements in or relating to milking apparatus
AU652970B2 (en)	1994-09-15	Squamous cell carcinoma-like immunoreactive antigen from human female urine
AU7575781A (en)	1982-04-22	Cyclopropane carboxylates and their use as insectides
AU3166093A (en)	1993-07-19	Induction heater
AU6710790A (en)	1991-05-31	Use of polymerized immunoglobulin to reduce the incidence of false-positive responses in immunoassays
AU622066B2 (en)	1992-03-26	Formulated milk for infants analogous to human milk
PL294075A1 (en)	1992-09-21	Gelly preparations dispersible in water
GB9106284D0 (en)	1991-05-08	Improvements in and relating to magnetic separators
GB9010359D0 (en)	1990-06-27	Enzyme and its preparation
EP0313333A3 (en)	1990-12-19	Bacterial strain
GB2251864B (en)	1995-02-01	Lactobacillus strains stable at low temperature
JPS55125712A (en)	1980-09-27	Suerlow electric delay line utilizing thin film inductor array by magnetic lift and coupling
EP0587765A4 (en)	1994-11-02	Induction of immune response against tetanus toxin through administration of mycobacteria expressing tetanus toxin or fragments.
AU5217890A (en)	1990-09-06	Monoclonal antibodies in vaccine formulations
KR890002159U (en)	1989-03-28	Manual food crusher
GB9108976D0 (en)	1991-06-12	Improvements in or relating to magnetic separators
AU1421492A (en)	1992-10-21	Ovine adipocyte antigens and their use in the immunological control of fat
Marshall	1987	Responses to lactation
PL271247A1 (en)	1988-11-24	Roller type silde with coupling device

Legal Events

Date	Code	Title	Description
1994-02-04	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1994-03-23	17P	Request for examination filed	Effective date: 19940104
1994-03-23	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE
1994-10-27	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN
1994-11-02	A4	Supplementary search report drawn up and despatched	Effective date: 19940916
1994-11-02	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE
1994-12-14	18W	Application withdrawn	Withdrawal date: 19941021